Organ and species specificity of hepatitis B virus (HBV) infection: A review of literature with a special reference to preferential attachment of HBV to human hepatocytes

被引:68
作者
DeMeyer, S [1 ]
Gong, ZJ [1 ]
Suwandhi, W [1 ]
vanPelt, J [1 ]
Soumillion, A [1 ]
Yap, SH [1 ]
机构
[1] UNIV HOSP GASTHUISBERG,DEPT LIVER & PANCREAT DIS,B-3000 LOUVAIN,BELGIUM
关键词
hepatitis B virus; attachment sites; preS1; preS2; small HBsAg; Annexin V;
D O I
10.1046/j.1365-2893.1997.00126.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B virus (HBV) infection is still a major public health problem worldwide. Although much information about the molecular biology of HEV has been gained in the last decades, little is known about the mechanism of attachment and penetration of the HBV particle into human hepatocytes. The HBV envelope proteins are important for the interaction between the HBV particle and the hepatocyte plasma membrane. Although initially it was suggested that the preS2 domain could act, via polymerized human serum albumin, as an attachment site to human hepatocytes, in recent years other observations showed that the preS1 domain is probably the most important attachment site to human hepatocytes. However, controversial findings on cellular proteins for binding to the preS1 domain has been described, namely the IgA-, the IL6-, the asialo-grycoprotein receptor and GAPD. Although the preS1 attachment site may be important, apo H has been shown to bind specifically to small HBsAg. Recently, we have identified human liver Annexin V as a specific small HBsAg-binding protein. In a preliminary report, the direct involvement of human Annexin V in the initial step of HBV infection has been demonstrated. A rat hepatoma cell line, which does not express human Annexin V and which is not infectable by HBV, gained the ability to become infected by HBV after transfection with human Annexin V. This result may facilitate the progress of HBV receptor research and elucidate the molecular mechanism of the initial step of HBV infection.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 92 条
[31]   A SYNTHETIC PEPTIDE VACCINE INVOLVING THE PRODUCT OF THE PRE-S(2) REGION OF HEPATITIS-B VIRUS-DNA - PROTECTIVE EFFICACY IN CHIMPANZEES [J].
ITOH, Y ;
TAKAI, E ;
OHNUMA, H ;
KITAJIMA, K ;
TSUDA, F ;
MACHIDA, A ;
MISHIRO, S ;
NAKAMURA, T ;
MIYAKAWA, Y ;
MAYUMI, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) :9174-9178
[32]   RETROENDOCYTOSIS OF HIGH-DENSITY LIPOPROTEINS BY THE HUMAN HEPATOMA-CELL LINE, HEPG2 [J].
KAMBOURIS, AM ;
ROACH, PD ;
CALVERT, GD ;
NESTEL, PJ .
ARTERIOSCLEROSIS, 1990, 10 (04) :582-590
[33]   PROGRESS ON THE CONTROL OF HEPATITIS-B INFECTION THROUGH IMMUNIZATION [J].
KANE, MA .
GUT, 1993, 34 (02) :S10-S12
[34]   X-REGION-SPECIFIC TRANSCRIPT IN MAMMALIAN HEPATITIS-B VIRUS-INFECTED LIVER [J].
KANEKO, S ;
MILLER, RH .
JOURNAL OF VIROLOGY, 1988, 62 (11) :3979-3984
[35]   IDENTIFICATION OF PROTEIN-BINDING SITES IN THE HEPATITIS-B VIRUS ENHANCER AND CORE PROMOTER DOMAINS [J].
KARPEN, S ;
BANERJEE, R ;
ZELENT, A ;
PRICE, P ;
ACS, G .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5159-5165
[36]   THE HBV HBX GENE EXPRESSED IN ESCHERICHIA-COLI IS RECOGNIZED BY SERA FROM HEPATITIS PATIENTS [J].
KAY, A ;
MANDART, E ;
TREPO, C ;
GALIBERT, F .
EMBO JOURNAL, 1985, 4 (05) :1287-1292
[37]   HEPATITIS-B VIRUS TRANSACTIVATOR HBX USES A TUMOR PROMOTER SIGNALING PATHWAY [J].
KEKULE, AS ;
LAUER, U ;
WEISS, L ;
LUBER, B ;
HOFSCHNEIDER, PH .
NATURE, 1993, 361 (6414) :742-745
[38]  
Kock J, 1996, HEPATOLOGY, V23, P405
[39]   INTERACTION BETWEEN HEPATITIS-B SURFACE-PROTEINS AND MONOMERIC HUMAN SERUM-ALBUMIN [J].
KRONE, B ;
LENZ, A ;
HEERMANN, KH ;
SEIFER, M ;
LU, XY ;
GERLICH, WH .
HEPATOLOGY, 1990, 11 (06) :1050-1056
[40]   STRUCTURE OF HEPATITIS-B DANE PARTICLE DNA AND NATURE OF ENDOGENOUS DNA-POLYMERASE REACTION [J].
LANDERS, TA ;
GREENBERG, HB ;
ROBINSON, WS .
JOURNAL OF VIROLOGY, 1977, 23 (02) :368-376